enVVeno Medical Corp
Change company Symbol lookup
Select an option...
NVNO enVVeno Medical Corp
MTBC CareCloud Inc
WRK Westrock Co
SNDX Syndax Pharmaceuticals Inc
SLAMU Slam Corp
SURYY Sumitomo Realty & Development Co Ltd
MKKGY Merck KGaA
DAC Danaos Corp
YY JOYY Inc
MGU Macquarie Global Infrastructure Total Return Fund Inc.
Go

Health Care : Health Care Equipment & Supplies | Small Cap Growth
Company profile

enVVeno Medical Corporation is a med-tech company. The Company is focused on improving the standard of care in the treatment of venous disease. The Company is focused on developing tissue-based solutions that are designed for patients with chronic venous insufficiency (CVI). Its lead product, VenoValve, is a porcine based device being developed to surgically implanted in the deep venous system of the leg to treat severe CVI, including the potential to heal recurring venous leg ulcers. The VenoValve is designed to be implanted into the femoral vein of the patient in an open surgical procedure via a five-to-six-inch incision in the upper thigh. The VenoValve is being evaluated in the surgical anti-reflux venous valve endoprosthesis (SAVVE) United States clinical trial. In addition to the VenoValve, the Company is focused on the development of a second device, enVVe, for the treatment of venous disease.

Closing Price
$4.22
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
25,424
0

Illumina Inc. Stock Falls Friday, Underperforms Market

5:01 pm ET January 21, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Illumina Inc. (ILMN) slid 3.81% to $365.94 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.89% to 4,397.94 and Dow Jones Industrial Average falling 1.30% to 34,265.37. This was the stock's second consecutive day of losses. Illumina Inc. closed $189.83 below its 52-week high ($555.77), which the company reached on February 12th.

The stock underperformed when compared to some of its competitors Friday, as Thermo Fisher Scientific Inc. (TMO) fell 1.33% to $580.33, Danaher Corp. (DHR) fell 0.89% to $280.45, and Agilent Technologies Inc. (A) fell 1.41% to $137.51. Trading volume (1.1 M) eclipsed its 50-day average volume of 1.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 21, 2022.

-MarketWatch Automation

	

(END) Dow Jones Newswires

January 21, 2022 17:01 ET (22:01 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.